A Phase 3 Clinical Trial of Leriglitazone with Adaptive Placebo-Controlled Treatment Duration in Adults with Cerebral Adrenoleukodystrophy Fatemi, A., Koehler, W., Eichler, F., Mochel, F., Sadjadi, R., Lund, T., Sampson, J., Shuhaiber, H., Amartino, H., Sgobbi, P., Kappler, M., Kay, R., Pina, G., Mistry, A., Pascual, M., Pascual, S., Martinell, M. WILEY. 2023: S138-S139

View details for Web of Science ID 001084474200208